Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial
Titel:
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trial
Auteur:
Krop, Ian E Mayer, Ingrid A Ganju, Vinod Dickler, Maura Johnston, Stephen Morales, Serafin Yardley, Denise A Melichar, Bohuslav Forero-Torres, Andres Lee, Soo Chin de Boer, Richard Petrakova, Katarina Vallentin, Susanne Perez, Edith A Piccart, Martine Ellis, Matthew Winer, Eric Gendreau, Steven Derynck, Mika Lackner, Mark Levy, Gallia Qiu, Jiaheng He, Jing Schmid, Peter